Medicine Jan 16
Results from CLARITY study show Cosentyx (secukinumab) was significantly more effective than Stelara * (ustekinumab) in delivering clear and almost clear skin at 12 weeks and at 16 weeks Data support findings from the CLEAR study, which found Cosentyx was superior to Stelara * in achieving sustained skin clearance (PASI 90) at 52 weeks Cosentyx
Architecture Jan 15

Better thermal insulation means lower heating costs - but this should not be at the expense of exciting architecture.

Microtechnics Jan 15

Researchers at EPFL have developed a system that can be installed in a building to collect data on people's energy usage.

Selected Job Offers
Employers of the Week
Bundesamt für Gesundheit BAG
ZHAW Zürcher Hochschule für Angewandte Wissenschaften
University of Geneva
Fachhochschule Nordwestschweiz FHNW
HES-SO Genève
Berner Fachhochschule